scholarly article | Q13442814 |
P2093 | author name string | E J Brown | |
E Rieder | |||
B Baxt | |||
S Neff | |||
P W Mason | |||
S D Blystone | |||
D Sá-Carvalho | |||
P2860 | cites work | The major human rhinovirus receptor is ICAM-1 | Q24306500 |
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily | Q24306525 | ||
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses | Q24312224 | ||
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry | Q24673735 | ||
Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding | Q24673765 | ||
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses | Q24678291 | ||
Structure of a major immunogenic site on foot-and-mouth disease virus | Q27732027 | ||
Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity | Q27733366 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Purification of the putative coxsackievirus B receptor from HeLa cells | Q28237765 | ||
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family | Q28295196 | ||
Vitronectin and its receptors | Q28298613 | ||
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
Animal cell mutants defective in glycosaminoglycan biosynthesis | Q28305815 | ||
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype | Q28646874 | ||
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
Requirement of vascular integrin alpha v beta 3 for angiogenesis | Q29619681 | ||
A pathogenesis study of foot-and-mouth disease in cattle, using in situ hybridization | Q34094386 | ||
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro | Q34201497 | ||
cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. | Q34285491 | ||
Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor | Q34346157 | ||
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution | Q34446528 | ||
Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus | Q35077224 | ||
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway | Q35082522 | ||
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). | Q35835449 | ||
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells | Q35838328 | ||
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition | Q35844566 | ||
Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. | Q35847135 | ||
Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions | Q35862137 | ||
Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus | Q35906814 | ||
Integrin beta 3 cytoplasmic tail is necessary and sufficient for regulation of alpha 5 beta 1 phagocytosis by alpha v beta 3 and integrin-associated protein | Q36235842 | ||
Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. | Q36240271 | ||
Viral cell recognition and entry | Q36278326 | ||
Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. | Q36382983 | ||
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans | Q36531041 | ||
Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan | Q36532155 | ||
Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells | Q36651749 | ||
Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2 | Q36654663 | ||
Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. | Q36773071 | ||
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate | Q36779935 | ||
Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus | Q36799311 | ||
Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. | Q36806517 | ||
Molecular cloning of the hepatitis A virus receptor from a simian cell line | Q36871270 | ||
Cell-surface interactions of echovirus 22. | Q36876854 | ||
A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis | Q36891922 | ||
Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus | Q37341614 | ||
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. | Q39870463 | ||
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD | Q39871734 | ||
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses | Q39872262 | ||
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. | Q39875541 | ||
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle | Q39875702 | ||
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells | Q39878039 | ||
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. | Q39880172 | ||
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro. | Q39882134 | ||
Pathogenesis of foot-and-mouth disease: the lung as an additional portal of entry of the virus | Q40020968 | ||
Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. | Q40038672 | ||
VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. | Q40040818 | ||
Identification and characterization of the cell surface 70-kilodalton sialoglycoprotein(s) as a candidate receptor for encephalomyocarditis virus on human nucleated cells. | Q40042452 | ||
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice | Q40046794 | ||
Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment | Q40133798 | ||
Binding and internalization of microorganisms by integrin receptors | Q40742836 | ||
Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo | Q41080592 | ||
Cell attachment and mouse virulence of echovirus 9 correlate with an RGD motif in the capsid protein VP1. | Q41104044 | ||
Post-translational modifications of alpha5beta1 integrin by glycosaminoglycan chains. The alpha5beta1 integrin is a facultative proteoglycan | Q41110672 | ||
Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions | Q41112994 | ||
Molecular evolution of aphthoviruses | Q41128941 | ||
Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells | Q41138783 | ||
A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors | Q41150504 | ||
Efficient RGD-independent entry process of coxsackievirus A9. | Q41245105 | ||
Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin | Q41492752 | ||
Effect of lysosomotropic compounds on early events in foot-and-mouth disease virus replication | Q41913787 | ||
BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface | Q42101846 | ||
The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells | Q44074351 | ||
Distribution of integrin cell adhesion receptors in normal and malignant lung tissue | Q44429276 | ||
A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses | Q44579256 | ||
Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. | Q45771643 | ||
Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR. | Q45790620 | ||
Early interactions of foot-and-mouth disease virus with cultured cells | Q45803463 | ||
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). | Q45845848 | ||
Host cell selection of antigenic variants of foot-and-mouth disease virus | Q45847273 | ||
Relationship between the cellular distribution of the alpha(v)beta3/5 integrins and adenoviral infection in salivary glands | Q45883284 | ||
Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types | Q45888027 | ||
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor | Q46190542 | ||
The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle | Q55062458 | ||
Competition for cellular receptor sites among selected aphthoviruses | Q67263483 | ||
Identification of the integrin VLA-2 as a receptor for echovirus 1 | Q68082141 | ||
Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor | Q71639316 | ||
Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors | Q73091334 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | foot-and-mouth disease | Q152401 |
foot-and-mouth disease virus | Q1911079 | ||
P304 | page(s) | 3587-3594 | |
P577 | publication date | 1998-05-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor | |
P478 | volume | 72 |
Q40197802 | A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells |
Q27469802 | Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo |
Q38694615 | Adaption of FMDV Asia-1 to Suspension Culture: Cell Resistance Is Overcome by Virus Capsid Alterations |
Q40723509 | Adenovirus inhibition by peptidomimetic integrin antagonists |
Q45370424 | Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles. |
Q40368026 | Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle |
Q40409606 | Analysis of foot-and-mouth disease virus internalization events in cultured cells |
Q39604531 | Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry |
Q34793068 | Aspects of the persistence of foot-and-mouth disease virus in animals--the carrier problem |
Q38354087 | Bactrian camel (Camelus bactrianus) integrins alphavbeta3 and alphavbeta6 as FMDV receptors: molecular cloning, sequence analysis and comparison with other species |
Q47546891 | Beyond the Matrix: The Many Non-ECM Ligands for Integrins. |
Q39589175 | Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage |
Q93161933 | Cellular DNAJA3, a Novel VP1-Interacting Protein, Inhibits Foot-and-Mouth Disease Virus Replication by Inducing Lysosomal Degradation of VP1 and Attenuating Its Antagonistic Role in the Beta Interferon Signaling Pathway |
Q39550459 | Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. |
Q42242588 | Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle |
Q36945437 | Conservation of the glycoprotein B homologs of the Kaposi׳s sarcoma-associated herpesvirus (KSHV/HHV8) and old world primate rhadinoviruses of chimpanzees and macaques |
Q42261472 | Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus |
Q41014903 | Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus |
Q36178513 | Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines |
Q45747044 | Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. |
Q39767380 | Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response |
Q84832664 | Differences in the virulence of two strains of Foot-and-Mouth Disease Virus Serotype A with the same spatiotemporal distribution |
Q38699140 | Differential replication of Foot-and-mouth disease viruses in mice determine lethality |
Q39602859 | Echoviruses bind heparan sulfate at the cell surface. |
Q33986070 | Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor |
Q45350762 | Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells |
Q36105475 | Establishment and evaluation of a murine ανβ3-integrin-expressing cell line with increased susceptibility to Foot-and-mouth disease virus |
Q39733475 | Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals |
Q40462658 | Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity. |
Q39699119 | Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo |
Q39604130 | Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding |
Q35627059 | Evolution of cell recognition by viruses: a source of biological novelty with medical implications |
Q35044856 | Evolution of foot-and-mouth disease virus |
Q36541684 | Examination of soluble integrin resistant mutants of foot-and-mouth disease virus |
Q34547126 | Foot-and-mouth disease |
Q39228592 | Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis |
Q34741667 | Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. |
Q41914096 | Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness |
Q39700273 | Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses |
Q34935334 | Foot-and-mouth disease virus: biology and prospects for disease control |
Q58775200 | Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays |
Q33796680 | Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus |
Q33569144 | Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. |
Q43745831 | Genetic variation of foot-and-mouth disease virus isolates recovered from persistently infected water buffalo (Bubalus bubalis). |
Q40128599 | Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host |
Q35785100 | Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses |
Q36898643 | Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis |
Q40885324 | High affinity interactions of Coxsackievirus A9 with integrin alphavbeta3 (CD51/61) require the CYDMKTTC sequence of beta3, but do not require the RGD sequence of the CAV-9 VP1 protein. |
Q39592588 | High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit |
Q37374909 | Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus |
Q33806424 | Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors |
Q57463113 | ITGB1b-Deficient Rare Minnows Delay Grass Carp Reovirus (GCRV) Entry and Attenuate GCRV-Triggered Apoptosis |
Q33944915 | In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. |
Q40835010 | Inability of FMDV replication in equine kidney epithelial cells is independent of integrin αvβ3 and αvβ6. |
Q40256031 | Inclusion of an Arg-Gly-Asp receptor-recognition motif into the capsid protein of rabbit hemorrhagic disease virus enables culture of the virus in vitro. |
Q44551896 | Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus |
Q45728822 | Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). |
Q33841904 | Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase |
Q41446161 | Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate. |
Q38736899 | Insights into Jumonji C-domain containing protein 6 (JMJD6): a multifactorial role in foot-and-mouth disease virus replication in cells |
Q40545957 | Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. |
Q39682189 | Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus |
Q40567879 | Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. |
Q34395684 | Integrin β3 is required in infection and proliferation of classical swine fever virus |
Q37111080 | Integrins modulate the infection efficiency of West Nile virus into cells |
Q37492311 | Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins |
Q38872782 | Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field. |
Q28236244 | Manipulation of cell surface macromolecules by flaviviruses |
Q39679224 | Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses |
Q35044850 | Molecular basis of pathogenesis of FMDV. |
Q35000918 | Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. |
Q37036808 | Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in mice |
Q38791120 | Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation |
Q39799982 | Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes |
Q33960512 | Picornavirus uncoating |
Q42183812 | Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions |
Q36499331 | Productive Entry of Foot-and-Mouth Disease Virus via Macropinocytosis Independent of Phosphatidylinositol 3-Kinase |
Q40090477 | Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol |
Q39583388 | Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism |
Q39997584 | Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. |
Q39982447 | Role of Jumonji C-domain containing protein 6 (JMJD6) in infectivity of foot-and-mouth disease virus |
Q39934665 | Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells. |
Q39602424 | Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus |
Q30854552 | Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus |
Q38760885 | Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. |
Q35291117 | Structural basis of nonenveloped virus cell entry |
Q35044853 | Structure and receptor binding. |
Q27469309 | Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry |
Q37260718 | Targeting the porcine immune system--particulate vaccines in the 21st century |
Q39601326 | The ability of integrin alpha(v)beta(3) To function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains |
Q39584959 | The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus |
Q27469718 | The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate |
Q35177505 | The pathogenesis and diagnosis of foot-and-mouth disease. |
Q38328829 | The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. |
Q45616527 | Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. |
Q41889160 | Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-and-mouth disease virus |
Q39604160 | Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells |
Q27013917 | Viral quasispecies evolution |
Q41741560 | Virus-host interactions in persistently FMDV-infected cells derived from bovine pharynx |
Q27472821 | West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection |
Search more.